SynthesisBreast (Edinburgh, Scotland)2021

Risk of recurrence among patients with HR-positive, HER2-negative, early breast cancer receiving adjuvant endocrine therapy: A systematic review and meta-analysis.

Elizabeth M Salvo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.